June 20, 2014

Latin America Insulin Market (Rapid Acting, Short Acting, Pre-Mixed, Long Acting, Type I & II Diabetes, Analogs Insulin) is Expected to Reach USD 3,760.7 Million by 2020

Market Size - $1,326.6 Mn 2013, Market Growth - CAGR of 16.2%, Market Trends –Innovations such as ultra-long acting analogs new report by Grand View Research. View full report with TOC - http://www.grandviewresearch.com/industry-analysis/latin-merica-insulin-market.

San Francisco, California (PRWEB) June 20, 2014

The Latin America market for Insulin is expected to reach USD 3,760.7 million by 2020, according to a new study by Grand View Research, Inc. Growing prevalence of diabetes (type I and type II) coupled with government initiatives to develop insulin in markets such as Brazil by providing medical and financial aid to the population in the form of subsidies and the entrance of multinational companies such as Novo Nordisk, Sanofi Aventis, etc is expected to drive regional insulin market. Affordability of medicines is perceived to be a key challenge for market development, as a significant part of the population may not be able to afford the product.

In 2013, Type II applications lead the regional market, with revenue of USD 1,183.7 million and are expected to grow at a CAGR of 15.8 % from 2014 to 2020. Type I applications are expected to have faster growth, at an estimated CAGR of 20.3 % from 2014 to 2020.

The report “Latin America (Brazil, Argentina, Chile, Mexico, Colombia, Venezuela) Insulin Market (Rapid Acting, Short Acting, Pre-Mixed, Long Acting, Type I & II Diabetes, Analogs, Recombinant) Analysis And Segment Forecasts To 2020,” is available now to Grand View Research customers and can also be purchased directly at http://www.grandviewresearch.com/industry-analysis/latin-merica-insulin-market.

Request free sample of this report at http://www.grandviewresearch.com/industry-analysis/latin-merica-insulin-market/request.

Further key findings from the study suggest:

  • Long acting products dominated insulin demand in Latin America, with estimated revenue of USD 548.6 million in 2013. Other leading products include rapid acting and premixed analogs, with the latter expected to grow at a CAGR of 14.3 % from 2014 to 2020.
  • In 2013, Analog was a dominant insulin source and is expected to grow at a CAGR of 17.7 % from 2014 to 2020.
  • R&D initiatives, changing lifestyle affecting health of people specially children and growing rate of old aged (above 40) population are also expected to have a positive influence on market demand.
  • In 2013, Brazil was the largest regional insulin market in terms of revenue, accounting for 38.0% share of Latin American demand, followed by Mexico and Argentina. Brazil insulin demand is estimated to grow at a fastest CAGR of 18.2 % from 2014 to 2020.
  • Some of the key manufacturers in Latin American insulin market include Sanofi Aventis, Novo Nordisk, Nanjing Xinbai Pharmaceutical Co. Ltd, Takeda Pharmaceuticals, Eli Lilly and Company.

Browse all reports of Pharmaceuticals Market Published by Grand View Research at http://www.grandviewresearch.com/industry/pharmaceuticals.

For the purpose of this study, Grand View Research has segmented the Asia Pacific Insulin market on the basis of product, application, source and region:

  •      Insulin Product Outlook

            • Rapid acting

            • Long acting

            • Premixed

            • Premixed analog

            • Short acting

            • Intermediate acting

  •      Insulin Application Outlook

            • Type II and Other Diabetes

            • Type I Diabetes

  •      Insulin Source Outlook

            • Human Recombinant

            • Analogs

  •      Insulin Regional Outlook

            • Brazil

            • Argentina

            • Chile

            • Mexico

            • Colombia

            • Venezuela

            • Peru

            • Rest of Latin America

Browse all Grand View Research ongoing reports at http://www.grandviewresearch.com/ongoing-reports.

Latest Reports By Grand View Research:

Global Cellulose Fibers Market By Application (Spun Yarn, Fabrics, Clothing) Expected to Reach USD 29,611.1 Million by 2020 (http://www.grandviewresearch.com/industry-analysis/cellulose-fibers-market)

The global market for cellulose fibers is expected to reach USD 29,611.1 million by 2020, according to a new study by Grand View Research, Inc. Low prices of raw material coupled with regulatory supports offered by various countries are expected to be key driving factors for the market. In addition, the augmented demand for clothing and apparel in emerging economies is also expected boost the demand for cellulose fibers. However, fluctuating prices of raw material is expected to be a key challenge for market growth.

Global Coated Fabrics Market By Product (Polymer, Rubber, Fabric backed Wall Coverings), By Application (Transportation, Protective Clothing, Industrial, Furniture) Expected to Reach USD 22,576.7 Million by 2020 (http://www.grandviewresearch.com/industry-analysis/coated-fabrics-market)

The global market for coated fabrics is expected to reach USD 22,576.7 million by 2020, according to a new study by Grand View Research, Inc. Coated fabrics market is expected to witness rapid growth due to positive outlook on application markets and product innovation. Increasing growth in automotive industry is also expected to boost the coated fabrics market over the forecast period. Rising demand for protective clothing due to its wide application in food processing, agriculture, chemical processing is expected to fuel the market growth of coated fabrics. The global construction industry has seen a steady recovery over the last three years, enhanced infrastructure spending, particularly in Brazil, China and India is expected to be mirrored in the demand for coated fabrics.

About Grand View Research

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights. For more information, visit http://www.grandviewresearch.com/.


Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc

Phone: 1-415-349-0058

For the original version on PRWeb visit: http://www.prweb.com/releases/Latin_America_Insulin/Market_Share_Size_Trends/prweb11961941.htm